196 related articles for article (PubMed ID: 22476334)
1. Insight into Crohn's disease pathomorphology.
Mudter J; Neurath MF
Abdom Imaging; 2012 Dec; 37(6):921-6. PubMed ID: 22476334
[TBL] [Abstract][Full Text] [Related]
2. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
3. New therapies for inflammatory bowel disease: from the bench to the bedside.
Danese S
Gut; 2012 Jun; 61(6):918-32. PubMed ID: 22115827
[TBL] [Abstract][Full Text] [Related]
4. Investigation on lymphocyte subpopulations in the intestinal lamina propria in inflammatory bowel diseases.
Yuan SZ; Foster LP; Wang NS; Kraft SC
Chin Med J (Engl); 1992 Jan; 105(1):18-24. PubMed ID: 1576865
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
Rodrigues M; Zerbini MC; Barbieri D
Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the intestinal mucosal block in ulcerative colitis and Crohn's disease--immunological and ultrastructural findings, and considerations of the pathogenesis.
Gebbers JO; Otto HF
Klin Padiatr; 1985; 197(4):341-8. PubMed ID: 4046492
[TBL] [Abstract][Full Text] [Related]
7. Defects in mucosal immunity leading to Crohn's disease.
Cobrin GM; Abreu MT
Immunol Rev; 2005 Aug; 206():277-95. PubMed ID: 16048555
[TBL] [Abstract][Full Text] [Related]
8. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
9. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
[TBL] [Abstract][Full Text] [Related]
10. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.
Kugathasan S; Saubermann LJ; Smith L; Kou D; Itoh J; Binion DG; Levine AD; Blumberg RS; Fiocchi C
Gut; 2007 Dec; 56(12):1696-705. PubMed ID: 17682002
[TBL] [Abstract][Full Text] [Related]
11. Etiology and pathogenesis of inflammatory bowel disease.
Schmidt C; Stallmach A
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives.
Neurath MF
Arch Immunol Ther Exp (Warsz); 2000; 48(2):81-4. PubMed ID: 10807047
[TBL] [Abstract][Full Text] [Related]
13. A novel pathogenic role for microvasculature in inflammatory bowel disease.
Danese S; Papa A; Scaldaferri F; Graziani C; Bonizzi M; Armuzzi A; Fedeli G; Gasbarrini G; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2006; 10(1):3-5. PubMed ID: 16494103
[TBL] [Abstract][Full Text] [Related]
14. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease.
Xu XR; Liu CQ; Feng BS; Liu ZJ
World J Gastroenterol; 2014 Mar; 20(12):3255-64. PubMed ID: 24695798
[TBL] [Abstract][Full Text] [Related]
16. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; LĂ©mann M; Mayer L; Toubert A
Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
[TBL] [Abstract][Full Text] [Related]
17. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
18. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
[TBL] [Abstract][Full Text] [Related]
19. [Intestinal flora and Crohn's disease].
Desreumaux P; Colombel JF
Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
[TBL] [Abstract][Full Text] [Related]
20. Role of the innate immune system in the pathogenesis of inflammatory bowel disease.
van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]